Safety and Efficacy of Eltrombopag and Romiplostim in Myelodysplastic Syndromes: A Systematic Review and Meta-Analysis

BACKGROUND AND AIM: Many studies indicated that eltrombopag and romiplostim could improve hematopoietic function in patients with myelodysplastic syndromes (MDS), but their toxicity and efficacy were not known. This meta-analysis aimed to investigate the safety and efficacy of eltrombopag and romipl...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Fanqiao, Chen, Xiuqiong, Yu, Shunjie, Ren, Xiaotong, Liu, Zhaoyun, Fu, Rong, Li, Lijuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727449/
https://www.ncbi.nlm.nih.gov/pubmed/33324559
http://dx.doi.org/10.3389/fonc.2020.582686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727449/
https://www.ncbi.nlm.nih.gov/pubmed/33324559
http://dx.doi.org/10.3389/fonc.2020.582686

Ejemplares similares